|
|||||
|
|
Compliant treatment with anti‐copper agents prevents clinically overt Wilson's disease in pre‐symptomatic patients |
|
| Authors: | K. Dzieżyc M. Karliński T. Litwin A. Członkowska |
| Affiliation: | 1. Second Department of Neurology, Institute of Psychiatry and Neurology, , Warsaw, Poland;2. Department of Clinical and Experimental Pharmacology, Medical University of Warsaw, , Warsaw, Poland |
| Abstract: | |
| Keywords: | anti‐copper treatment family screening symptom development Wilson's disease |